Vivos Therapeutics (NASDAQ:VVOS) CEO Kirk Huntsman joined Steve Darling from Proactive to share news the company has signed a nationwide distribution agreement in the United States with Lincare, a prominent supplier of in-home respiratory therapy products and services catering to approximately 1.8 million patients. Huntsman highlighted that this agreement comes on the heels of a successful distribution pilot with Lincare, marking a significant milestone in Vivos' strategic approach to partnering with leading durable medical equipment companies in the United States. The collaboration with Lincare is a testament to the quality and potential of Vivos' devices in improving patient well-being.
As part of the agreement, Vivos has granted Lincare a six-month exclusivity period to distribute certain designated Vivos devices. This exclusivity underscores the commitment of both companies to leveraging their expertise and resources for the benefit of patients seeking effective solutions for respiratory health and overall well-being. In summary, Vivos Therapeutics (NASDAQ:VVOS), under the leadership of CEO Kirk Huntsman, is making significant strides in expanding its distribution network and reaching a broader patient base through its partnership with Lincare. This agreement marks a critical step in the company's mission to provide innovative and effective solutions for respiratory health, ultimately improving the lives of millions of patients across the United States.